Evidence map›Paper›PMID 26124145›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Enzyme mechanism-based, oxidative DNA-protein cross-links formed with DNA polymerase β in vivo.

Jason L Quiñones, Upasna Thapar, Kefei Yu, Qingming Fang, Robert William Sobol, Bruce Demple

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Targeting DNA-Protein CrosslinksFrontiers in molecular biosciences · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Topoisomerase Assays.Current protocols · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jason L QuiñonesDepartment of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, NY 11794;
Upasna ThaparDepartment of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, NY 11794;
Kefei YuDepartment of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824;
Qingming FangDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213.
Robert William SobolDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213.ORCID http://orcid.org/0000-0001-7385-3563
Bruce DempleDepartment of Pharmacological Sciences, Stony Brook University School of Medicine, Stony Brook, NY 11794; bruce.demple@stonybrook.edu.
Stony Brook University · USUniversity of Pittsburgh · USMichigan State University · US

Funding

Training Program in Pharmacological SciencesT32GM007518 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GARCIA-DIAZ, MIGUEL · 1985 to 2021
$5.4M
Novel approaches to enhance tumor cell cytotoxicity of alkylating agentsR01CA148629 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2010 to 2021
$3.4M
HUMAN REPAIR ENZYME FOR 3-FRAGMENTS IN OXIDIZED DNAR01GM040000 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI DEMPLE, BRUCE F. · 1988 to 2010
$2.8M
DNA repair deficient cells for analysisR44GM087798 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2010 to 2011
$2.5M
DNA repair deficient human cells for genomic variation analysisR43GM087798 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2009 to 2009
$200k
Formation and Fate of Oxidative DNA-Protein CrosslinksF31GM109747 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI QUINONES, JASON LUIS · 2014 to 2016
$90k
NCI NIH HHS CA148629NCI NIH HHS R01 CA148629NIGMS NIH HHS F31 GM109747NIGMS NIH HHS F31GM109747NIGMS NIH HHS GM040000NIGMS NIH HHS GM087798NIGMS NIH HHS R01 GM040000NIGMS NIH HHS R43 GM087798NIGMS NIH HHS R44 GM087798NIGMS NIH HHS T32 GM007518
6 · The paper itself

Abstract

Free radical attack on the C1' position of DNA deoxyribose generates the oxidized abasic (AP) site 2-deoxyribonolactone (dL). Upon encountering dL, AP lyase enzymes such as DNA polymerase β (Polβ) form dead-end, covalent intermediates in vitro during attempted DNA repair. However, the conditions that lead to the in vivo formation of such DNA-protein cross-links (DPC), and their impact on cellular functions, have remained unknown. We adapted an immuno-slot blot approach to detect oxidative Polβ-DPC in vivo. Treatment of mammalian cells with genotoxic oxidants that generate dL in DNA led to the formation of Polβ-DPC in vivo. In a dose-dependent fashion, Polβ-DPC were detected in MDA-MB-231 human cells treated with the antitumor drug tirapazamine (TPZ; much more Polβ-DPC under 1% O2 than under 21% O2) and even more robustly with the "chemical nuclease" 1,10-copper-ortho-phenanthroline, Cu(OP)2. Mouse embryonic fibroblasts challenged with TPZ or Cu(OP)2 also incurred Polβ-DPC. Nonoxidative agents did not generate Polβ-DPC. The cross-linking in vivo was clearly a result of the base excision DNA repair pathway: oxidative Polβ-DPC depended on the Ape1 AP endonuclease, which generates the Polβ lyase substrate, and they required the essential lysine-72 in the Polβ lyase active site. Oxidative Polβ-DPC had an unexpectedly short half-life (∼ 30 min) in both human and mouse cells, and their removal was dependent on the proteasome. Proteasome inhibition under Cu(OP)2 treatment was significantly more cytotoxic to cells expressing wild-type Polβ than to cells with the lyase-defective form. That observation underscores the genotoxic potential of oxidative Polβ-DPC and the biological pressure to repair them.

Indexed as

DNA DamageAnimalsCell Line, TumorDNADNA Polymerase betaHumansMiceOxidation-ReductionDNADNA Polymerase beta2-deoxyribonolactoneabasic siteAP lyasebase excision repairfree radical damage

Identifiers

PMID26124145
PMCPMC4507217
OpenAlexW1760601206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.